Curis Inc (CRIS) Stock Price, Quote & News

Company Profile

Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small-molecule IRAK4 kinase inhibitor, which is in a Phase 1/2 open-label, single-arm expansion trial in patients with relapsed or refractory, or R/R, AML and high-risk myelodysplastic syndromes. The company's pipeline also includes Fimepinostat, an oral dual inhibitor of HDAC and...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 503 6500

Website: www.curis.com

Address:

Building C, Suite 500 128 Spring Street, Lexington, United States

BallWasher69 Dec. 8 at 3:23 AM

$CRIS has anyone heard what new data they showed at ASH? Per their most recent PR: We are presenting at the ASH annual meeting in December with initial data from the ongoing frontline AML triplet study evaluating different dosing regimens of emavusertib, venetoclax, and azacitidine.

0 · Reply

prodigy_nyc Dec. 5 at 6:58 AM

$CRIS i stopped averaging down long time ago, so much regrets. had a choice to invest in pltr at 6-8$ but chosed this pos instead. over 100k in losses, have like 10k ish remaining, only holding to do tax loss harvesting when i make a decent chunk of profit. for newer investors in my shoe, dont do it, a blind AI pick will give you 1000% more than this pos will. on the side note, what “catalyst” does this pos have for it? not that i have my hopes up anymore lol

1 · Reply

Love_To_Learn Dec. 3 at 2:20 PM

$CRIS your 1.19 is fundamental for many stocks sub 1 and around u it is vital !

1 · Reply

timohe Dec. 2 at 8:16 AM

$CRIS $PFE Who knows… maybe a Pfizer giant will casually whisper ‘Curis’ over coffee at the next ASH.

0 · Reply

timohe Nov. 30 at 9:52 AM

$CRIS Just realized I was the genius who wrote that. Completely off… and yep, still waiting 🤦‍♂️😂

0 · Reply

eeeee14212 Nov. 29 at 3:24 PM

$CRIS damn I been watching this since 2018

0 · Reply

TCzeck Nov. 28 at 6:04 PM

$CRIS Another green day 👏🏻 Great company with great pipelines! Have a wonderful weekend everyone 🤙🏻

1 · Reply

TCzeck Nov. 26 at 5:35 PM

$CRIS Great buying pressure 🟢 It's almost time... 🤙🏻

0 · Reply

steveMero Nov. 25 at 4:52 PM

$CRIS once they file chapter 11 , they will release the data

1 · Reply

TCzeck Nov. 25 at 4:06 PM

$CRIS They must be awaiting for timing when they release data from the 3 presentations that took place November 21-23... I would have assumed it would be released to public by now, tells me they are waiting for a perfect moment of release.

1 · Reply

Curis to Present at Upcoming 30th Annual SNO Meeting

Nov 7, 2025, 1:56 PM EST - 4 weeks ago

Curis, Inc. (CRIS) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:00 PM EST - 4 weeks ago

Curis Provides Third Quarter 2025 Business Update

Oct 30, 2025, 4:00 PM EDT - 5 weeks ago

Curis to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on November 6, 2025

Oct 3, 2025, 4:00 PM EDT - 2 months ago

Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Sep 12, 2025, 9:45 AM EDT - 3 months ago

Curis, Inc. (CRIS) Presents At Cantor Global Healthcare Conference 2025 Transcript

Sep 11, 2025, 5:20 AM EDT - 3 months ago

Curis, Inc. (CRIS) Presents At H.C. Wainwright 27th Annual Global Investment Conference Transcript

Sep 2, 2025, 10:43 AM EDT - 3 months ago

Curis to Present at Upcoming Healthcare Conferences in September

Aug 5, 2025, 6:10 PM EDT - 4 months ago

Curis (CRIS) Q2 Loss Narrows 66%

Aug 5, 2025, 11:25 AM EDT - 4 months ago

Curis, Inc. (CRIS) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 8:00 AM EDT - 4 months ago

Curis Provides Second Quarter 2025 Business Update

Jul 29, 2025, 8:30 AM EDT - 4 months ago

Curis to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on August 5, 2025

Jul 2, 2025, 8:32 AM EDT - 5 months ago

Curis Announces $7.0 Million Registered Direct and Concurrent Private Placement

May 6, 2025, 2:40 PM EDT - 7 months ago

Curis, Inc. (CRIS) Q1 2025 Earnings Call Transcript

May 6, 2025, 8:00 AM EDT - 7 months ago

Curis Provides First Quarter 2025 Business Update

Apr 29, 2025, 8:00 AM EDT - 7 months ago

Curis to Report First Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on May 6, 2025

Apr 2, 2025, 4:05 PM EDT - 8 months ago

Curis to Present at Upcoming Healthcare Conference in April

Mar 31, 2025, 9:59 AM EDT - 8 months ago

Curis, Inc. (CRIS) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:00 AM EDT - 8 months ago

Curis Provides Fourth Quarter 2024 Business Update

Mar 28, 2025, 4:07 PM EDT - 9 months ago

Curis to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on March 31, 2025

Dec 10, 2024, 8:00 AM EST - 1 year ago

Curis Announces Additional Data from TakeAim Leukemia Study

Nov 14, 2024, 11:02 AM EST - 1 year ago

Curis, Inc. (CRIS) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 8:00 AM EST - 1 year ago

Curis Provides Third Quarter 2024 Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Curis to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on November 14, 2024

Oct 29, 2024, 6:04 AM EDT - 1 year ago

Curis Announces $12.1 Million Registered Direct and Concurrent Private Placement

Sep 23, 2024, 8:30 AM EDT - 1 year ago

Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer

Sep 17, 2024, 7:30 AM EDT - 1 year ago

Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference

Aug 1, 2024, 3:44 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q2 2024 Earnings Call Transcript

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Curis Provides Second Quarter 2024 Financial and Operating Update

Jul 25, 2024, 8:00 AM EDT - 1 year ago

Curis to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024

Jul 10, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conference in July

May 10, 2024, 8:00 AM EDT - 1 year ago

Curis to Present Updated Data from the TakeAim Leukemia Study

May 7, 2024, 8:08 PM EDT - 1 year ago

Curis, Inc. (CRIS) Q1 2024 Earnings Call Transcript

May 7, 2024, 8:00 AM EDT - 1 year ago

Curis Provides First Quarter 2024 Business Update

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024

Apr 4, 2024, 7:30 AM EDT - 1 year ago

Curis to Present at Upcoming Healthcare Conferences in April

Feb 8, 2024, 2:04 PM EST - 1 year ago

Curis, Inc. (CRIS) Q4 2023 Earnings Call Transcript

Feb 8, 2024, 8:00 AM EST - 1 year ago

Curis Provides Fourth Quarter 2023 Business Update

Feb 1, 2024, 8:00 AM EST - 2 years ago

Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024

Dec 12, 2023, 8:00 AM EST - 2 years ago

Curis Announces Initial Combination Study Data from its TakeAim Lymphoma Study

Dec 11, 2023, 8:00 AM EST - 2 years ago

Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH Conference

Dec 6, 2023, 8:00 AM EST - 2 years ago

Curis Announces Three Presentations at ASH

Dec 5, 2023, 8:00 AM EST - 2 years ago

Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in Melanoma

Nov 17, 2023, 9:04 AM EST - 2 years ago

Curis's stock rises as analysts see ‘the next Pharmacyclics'

Nov 2, 2023, 2:32 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 8:00 AM EDT - 2 years ago

Curis Provides Third Quarter 2023 Business Update

Oct 26, 2023, 8:30 AM EDT - 2 years ago

Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023

Sep 12, 2023, 8:00 AM EDT - 2 years ago

Curis Announces Date for the 2nd Symposium on IRAK4 in Cancer

Aug 3, 2023, 9:35 PM EDT - 2 years ago

Curis, Inc. (CRIS) Q2 2023 Earnings Call Transcript

BallWasher69 Dec. 8 at 3:23 AM

0 · Reply

prodigy_nyc Dec. 5 at 6:58 AM

1 · Reply

Love_To_Learn Dec. 3 at 2:20 PM

$CRIS your 1.19 is fundamental for many stocks sub 1 and around u it is vital !

1 · Reply

timohe Dec. 2 at 8:16 AM

$CRIS $PFE Who knows… maybe a Pfizer giant will casually whisper ‘Curis’ over coffee at the next ASH.

0 · Reply

timohe Nov. 30 at 9:52 AM

$CRIS Just realized I was the genius who wrote that. Completely off… and yep, still waiting 🤦‍♂️😂

0 · Reply

eeeee14212 Nov. 29 at 3:24 PM

$CRIS damn I been watching this since 2018

0 · Reply

TCzeck Nov. 28 at 6:04 PM

$CRIS Another green day 👏🏻 Great company with great pipelines! Have a wonderful weekend everyone 🤙🏻

1 · Reply

TCzeck Nov. 26 at 5:35 PM

$CRIS Great buying pressure 🟢 It's almost time... 🤙🏻

0 · Reply

steveMero Nov. 25 at 4:52 PM

$CRIS once they file chapter 11 , they will release the data

1 · Reply

TCzeck Nov. 25 at 4:06 PM

1 · Reply

TCzeck Nov. 25 at 3:11 AM

$CRIS I heard that as well upon JFK's granddaughter, very sad thing to be told your death date. Most people don't think twice about situations like so until they come close to death situations within themselves and they find how precious life truly is. I was pronounced dead for 7 minutes at age 12 from a tremendous dog attack lung puncture wounds, woke up as a humbled, loving and caring human. Takes moments like them to change someone... I am very sorry for your loss of a friend, my condolences your way 🙏🏻 I love people and love to talk, always here...

0 · Reply

southcherry Nov. 25 at 12:00 AM

$CRIS JFK's granddaughter, who is 34 and has small children, disclosed that she has AML with some horrible mutations that give her less than 1 year to live. I wish this would get approved. We lost a friend who was late 60s with this. He was same as she was, he felt fine, was playing golf, then gone within a few months. Was a healthy person up to that time. This cancer needs a cure now. 😞

0 · Reply

TCzeck Nov. 21 at 4:50 PM

$CRIS Great company with great presentations going on today and all weekend. Hoping for phenomenal news released late Sunday-Monday 🙏🏻

2 · Reply

DAWGNuts Nov. 20 at 5:10 PM

$GERN should sell the rights to Rytelo in EU for $75M and 20% royalties. Rent out $CRIS SF3Emavusertib (IRAK4 Inhibitor).and instantly become MDS powerhouse. Bringing in $5B annually.

1 · Reply

steveMero Nov. 20 at 3:43 PM

$CRIS they want to show good faith information to public and they are working together for bankruptcy in closed door .

0 · Reply

TCzeck Nov. 20 at 1:52 AM

$CRIS This will be one of them stocks you wake up to @ $5 per share gain with volume less than 2M, no one paying attention to the heart of why it rose before the rise. Then the little discord fellas will start buying at 50-120 percent and chasers will continue to chase... I can already see it, too many BIO stocks I see on top gainers rise with low volume due to promising clinical data news released. As an investor, it is in great interest to start remembering the history, fundamentals, news correlation, SEC filings and *timing when purchasing a stock prior to the rise. This indeed will have heads turning, feed board platforms roaring and people chasing the climb. I can't wait to come back to this post and share it like I do with many of my others after my stocks run 150 plus percent. All I have to say, I told you so... Patience!

2 · Reply

TCzeck Nov. 19 at 9:10 PM

$CRIS ~ Heavy hedge fund ownership ~ Recent 13G filings ~ Recent 13F filings ~ Needed to regain compliance by November 14th 2025 🤔 still listed... ~ 3 presentations with 3 seperate powerful companies November 21st, 22nd and 23rd. ~ 52W low held above $1 ~ Has cash and cash equilvalents going into Q1 2026 ~ Beats revenue estimates ~ Advances cancer trials with promising results ~ Completes sale of Erivedge Business Hard to wrap your head around all that news 😅 All I can say, when this rises tremendous percentages, you all will be chasing! Every BIO stock that I see up 200,400,600 percent in a day has news about promising clinical data (after presented). Can't wait for next week, Monday can't come more soon! The hedge fund ownership & secretly staying compliant with Nasdaq, shows me what this will do in the coming days 🤙🏻

0 · Reply

steveMero Nov. 19 at 8:07 PM

$CRIS Bankruptcy next week ?

0 · Reply

TCzeck Nov. 19 at 4:38 PM

$CRIS 🕰️

0 · Reply

TCzeck Nov. 17 at 6:55 PM

$CRIS Better start purchasing shares before Wednesday. Will be a hell of a runner from Wednesday-Monday.

1 · Reply

Topzero Nov. 17 at 6:28 PM

$CRIS Short Update for Investors The recent trading activity shows strong buying support, even with high selling volume. The price barely dropped, which indicates accumulation, not weakness. This usually suggests that investors are positioning themselves ahead of an expected announcement. Based on the latest filings and market behavior, the situation looks more positive than negative, and the risk-reward at this level is very attractive. In short: This is a strategic buy zone for those who want to enter before any major update.🔥🔥🔥🔥

1 · Reply

jeremy50641 Nov. 15 at 8:02 PM

$CRIS is this going to get delisted or did they get a extension?

0 · Reply

Market Cap	17.45M
Revenue (ttm)	10.91M
Net Income (ttm)	-43.39M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-397.71%
Debt to Equity Ratio	0.00

Volume	102,800
Avg Vol	89,910
Day's Range	N/A - N/A
Shares Out	12.93M
Stochastic %K	79%
Beta	4.02
Analysts	Strong Sell
Price Target	$14.50